ORIC
Oric Pharmaceuticals Inc
NASDAQ: ORIC · HEALTHCARE · BIOTECHNOLOGY
$9.44
-2.18% today
Updated 2026-04-29
Market cap
$977.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.47
Dividend yield
—
52W range
$5 – $15
Volume
2.1M
Oric Pharmaceuticals Inc (ORIC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-20.83M | $-20.68M | $-23.53M | $-45.27M | $-59.54M | $-75.14M | $-85.69M | $-112.66M | $-113.37M |
| Capital expenditures | $486000.00 | $525000.00 | $768000.00 | $667000.00 | $939000.00 | $2.08M | $849000.00 | $1.19M | $712000.00 |
| Depreciation | $900000.00 | $903000.00 | $1.03M | $970000.00 | $897000.00 | $966000.00 | $1.03M | $1.11M | — |
| Stock-based comp | $217.00 | $469000.00 | $1.09M | $5.28M | $12.85M | $14.46M | $15.23M | $20.21M | $25.04M |
| Free cash flow | $-21.32M | $-21.21M | $-24.30M | $-45.94M | $-60.48M | $-77.22M | $-86.54M | $-113.85M | $-114.08M |
| Investing cash flow | $-292000.00 | $-508000.00 | $-768000.00 | $-215.96M | $158.44M | $-109.25M | $-43.40M | $22.14M | — |
| Financing cash flow | $260000.00 | $38.01M | $70.82M | $250.51M | $49.13M | $25.23M | $85.66M | $126.55M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-10.71M | $148.03M | $-159.17M | — | — | — |